Document is current
Any future updates will be listed below
-
Authors
Freilich, Janet https://orcid.org/0000-0003-2272-1194
Kesselheim, Aaron S.
-
Funding
Funding for this research was provided by:
Commonwealth Fund
Arnold Ventures
- License Information
-
More Information
Article History
Accepted: 20 March 2025
First Online: 8 April 2025
Declarations
:
: Arnold Ventures and Commonwealth Fund.
: Dr. Kesselheim reports serving as an expert witness for a group of individuals in a case against Gilead relating to its tenofovir-containing products, for a group of payors in a case against J&J related to patents covering Stelara, and for a group of state attorneys general and payors in a case against generic drug manufacturers related to alleged price fixing. Dr. Kesselheim filed an amicus brief with the Supreme Court in Amgen v. Sanofi on behalf of Sanofi and was not compensated for his work. Dr. Kesselheim also reports serving as an investigator on a grant from the FDA Office of Generic Drugs relating to generic drug/device combinations. Prof. Freilich has no conflicts to disclose.
